Opioid-induced bowel dysfunction pivotal assessment of lubiprostone (OPAL)
2/12/2008

Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Canada. www.clinicaltrials.gov.

Related Summaries